HIGHLIGHTS
- who: Norman Abbou et al. from the Molecular Biology Laboratory, North University Hospital, Marseille, France have published the article: Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm, in the Journal: Cells 2023, 12, 105. of /2023/
- what: The aim of this short review is to highlight the impact of molecular biology on the diagnosis and management of patients with PV ET and PMF.
SUMMARY
BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are a group of stem_cell disorders characterized by aberrant hematopoietic proliferation with an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.